160 HEALTH (02656) saw its gains expand to over 47%. At the time of writing, the stock was up 45.01%, trading at HK$23.26 with a turnover of HK$1.475 billion. The surge follows a recent company announcement highlighting a breakthrough in its "160 AI Hospital" operational cooperation model. Between January 2025 and the end of March 2026, the company has secured operational partnerships with a cumulative total of 102 public medical institutions. Among these, 54 are top-tier Grade A tertiary hospitals, accounting for 52.9% of the total. The number of tertiary hospitals and above reached 78, representing 76.5% of all partnered institutions. Analysts note that market perception of the company is shifting from a "low-margin appointment booking platform" to a "high-margin AI healthcare ecosystem operator," a discrepancy expected to drive significant value re-rating. Benefiting from the rapid development of businesses such as AI cloud hospitals, 160 HEALTH is currently in a phase of accelerated profit expansion, with a target price of HK$102.19.